R&D Capability
Home Innovation

R&D Capability

R&D Capability

Remarkable R&D capabilities with over 20 years of R&D experience, Jiangsu Hansoh Pharma has several national-level R&D destinations, including the National Enterprise Technology Centers, Post-doctoral Research Station, and Key National Laboratory. The Company is highly efficient to discover innovative drugs, with R&D structure that covers areas such as peptides, biologics, small molecules, ADC drugs, and siRNAs.

  • 7
    launched innovative drugs
  • 30 +
    innovative drug programs in different clinical stages
  • 50 +
    clinical trials of innovative drugs
  • 60 +
    national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
  • 2
    second prizes of National Science and Technology Progress Award
  • 2
    China Patent Gold Award
  • 600 +
    authorized invention patents at home and abroad
  • 200 +
    contributions to national standards
R&D Team
  • 3
    State Council Special Allowance Experts
  • 16
    Jiangsu "innovative and entrepreneurial talent"
  • 9
    Jiangsu "333 talent project"
  • 1700 +
    R&D fellows in China and abroad
Baidu
sogou